Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
4
×
wisconsin top stories
alzheimer's disease
biogen
bristol-myers squibb
cancer immunotherapy
drug prices
merck
novartis
pfizer
president trump
startups
albert bourla
What
drug
bio
roundup
prices
today
acquisitions
albert
alzheimer’s
annual
approval
assessed
attention
away
biggest
biogen’s
biopharmaceutical
biotech
bourla
bringing
ceo
ceos
communities
companies
company
conference
convo
crispr
dc
earlier
esmo
europe
executives
failures
future
gathered
germany
groups
hearing
held
hosted
Language
unknown
Current search:
medicare
×
" wisconsin blog main "
×
abbvie
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More